The market is nearly back at all time highs, yet there are still plenty of opportunities.Cheap foundational stocks:- $Alphabet(GOOG)$ - $UnitedHealth(UNH)$ - $Novo-Nordisk A/S(NVO)$ Cheap growth stocks:- $Oscar Health, Inc.(OSCR)$ - $Advanced Micro Devices(AMD)$ - $Nu Holdings Ltd.(NU)$ These are the stocks I would buy if I were to allocate capital now.For whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlim

$Palantir Technologies Inc.(PLTR)$ recently retested the $100 level multiple times and held strong, showing clear demand at that psychological zone. A break above $142 could trigger the next leg higher, potentially sending PLTR toward the much-talked-about $200 level.Yes, valuation concerns are valid, but we’ve seen this narrative before. Think $Tesla Motors(TSLA)$ in its early breakout stages: plenty of skeptics, but price ignored the noise and kept running. Palantir might be setting up for something similar.Our initial target remains $200 — but based on current strength, the deals in the pipeline, and the AI narrative expanding globally, that might end up being too conservative.Some Key Drivers Behind t

The big run of artificial intelligence stocks has taken a breather in 2025 but a couple of plays are hanging in there, such as Palantir Technologies (PLTR). While semiconductor stocks ruled as the best AI stocks early on, there could be new options emerging.To be sure, top AI stocks such as $Microsoft(MSFT)$ and $NVIDIA(NVDA)$ face high expectations. For many companies — such as Google parent $Alphabet(GOOG)$ , $Amazon.com(AMZN)$ and Facebook parent $Meta Platforms, Inc.(META)$ — the rise of generative AI poses both risk and opportunity.Amid the rise of generative AI — which gen

1. $NEBIUS(NBIS)$ raises $1 billion through convertible bond offering and the market hammers it down 5%…People don’t really get it, they are pricing the effect of dilution on its face…2.5% average interest rate with an initial conversion price of $51.This is insanely bullish!Are you aware that this is a company growing revenue three digits YoY?The ROI on this will be much, much higher than the combined effect of interest paid and potential dilution.Bullish.2. $Oscar Health, Inc.(OSCR)$ valuation is completely ridiculous...- Grew revenues 67% annually since 2021.- Highest NPS score in the industry.- Trading at 7 times 2027 earnings.And this is considering that enhanced ACA subsidies will expire this year.W

$AST SpaceMobile, Inc.(ASTS)$ $Rocket Lab USA, Inc.(RKLB)$ So no -- these companies aren’t in competition. Rocket Lab is building the secure, modular, defense-aligned architecture to operate above the Earth. ASTS is embedding persistent connectivity into the same zone, for consumers, enterprises, and agencies alike. One is defining how we project power. The other is defining how we stay connected. They don’t overlap. They interlock.xWe’re finally in the post-launch phase of the space economy -- where the real value isn’t in who gets to orbit, but in who controls what happens once you’re there. We still talk about launches the way we talked about dial-up modems in the early internet: who can get there fast

$NVIDIA(NVDA)$ $Advanced Micro Devices(AMD)$ Both Nvidia and AMD now trade at similar forward earnings multiples -- 28x for Nvidia and 26x for AMD -- a convergence that would have seemed absurd during the AI melt-up in early 2024, when Nvidia’s multiple topped 60 and AMD’s hovered in the low 30s. At face value, the market is signaling parity. But the multiple is a mirage -- because these companies aren’t converging. They’re diverging into opposite ends of the AI stack.We were told there could only be one. That the AI revolution would consolidate around a singular force. And for a time, it did. Nvidia wasn’t just dominant in training -- it was the training cycle. CUDA became the operating system of intellig